Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

$Monopar Therapeutics (MNPR.US)$ Monopar Therapeutics Inc ([...

$Monopar Therapeutics (MNPR.US)$ Monopar Therapeutics Inc (MNPR  Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Soumit Roy from JonesTrading upgraded the rating on the stock to a Buy and gave it a $2.00 price target.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
4527 Views
Comment
Sign in to post a comment
    61Followers
    33Following
    520Visitors
    Follow